Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Merck closes exclusive global license agreement for LM-299 Ruchika Sharma23 Dec 2024 4:01 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global license agreement for LM-299, a...
Merck, Hansoh Pharma ink pact for oral small molecule GLP-1 receptor agonist Ruchika Sharma20 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have announced that...
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
Merck discontinues clinical development programs for vibostolimab, favezelimab Ruchika Sharma18 Dec 2024 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the clinical development programs for...
Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With Advanced Epithelial Ovarian Cancer: Merck Ruchika Sharma11 Dec 2024 5:54 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA...
ZENITH Trial Breakthrough: Winrevair Shows Significant Impact on Outcomes of Pulmonary Arterial Hypertension Medha Baranwal4 Dec 2024 8:00 PM ISTUSA: In patients with advanced pulmonary arterial hypertension (PAH), adding the biologic sotatercept-csrk (Winrevair; Merck) to the maximum tolerated...
USFDA grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for Metastatic Nonsquamous Non Small Cell Lung Cancer with EGFR Mutations: Merck Ruchika Sharma4 Dec 2024 1:01 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted...
Merck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment Farhat Nasim20 Nov 2024 2:01 PM ISTMerck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of lung cancer.
Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma Ruchika Sharma19 Nov 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Ginkgo Bioworks advances collaboration with Merck to improve Biologics manufacturing Ruchika Sharma14 Nov 2024 12:33 PM ISTBoston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of...
Merck, Moderna begin Phase 3 Trial of V940 with Keytruda in non small lung cancer Ruchika Sharma3 Nov 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath-009, a pivotal...
